[Can the symptoms of stroke be limited?].
Lindsberg
P J
PJ
HYKS:n neuroklinikka, Helsinki.
Kaste
M
M
D000818:Animals; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D009569:Nitric Oxide / Q000378:metabolism; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000188:drug therapy* / Q000473:pathology; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use
D018696:Neuroprotective Agents; D016222:Fibroblast Growth Factor 2; D009569:Nitric Oxide; D010959:Tissue Plasminogen Activator